InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Discover the complete record of transactions filed by Yilmaz Mahshid, Chief Financial Officer. Director active across 1 companies, notably Egetis Therapeutics AB (publ). In total, 2 filings have been logged. The latest transaction was disclosed on 13 May 2026 — Sale. Regulator: FIN-FSA. All data is accessible without signup.
Declarations2 total
SEK 91,386153,631 shares@ SEK 0.59480.0043% mcap100.0% of flow
Aktie
FI:A003Y582-1·
€21,05560,000 shares@ €0.35090.0010% mcap18.7% of flow
Aktie
FI:A003U276-2·
Ideal exit: 23 Aug 2026 (T+270)
2 of 2 declarations
About Yilmaz Mahshid
Yilmaz Mahshid is the Chief Financial Officer of Egetis Therapeutics AB (publ). In this role, he is responsible for the financial management of the company, including budgeting and financial analysis. His expertise is essential to ensure the financial health of the organization.
